Detalhe da pesquisa
1.
More Children Means More Tumours? We Can Do More to Protect the Health of Our Kids-A Call for a New Epidemiology That Can Change the World.
Epidemiologia (Basel)
; 4(2): 173-175, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37367183
2.
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Breast Cancer Res Treat
; 125(3): 775-84, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21132360
3.
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
Breast Cancer Res Treat
; 116(2): 303-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18821012
4.
Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.
Cancer Genet Cytogenet
; 182(2): 75-83, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18406868
5.
Disease family history and modification of breast cancer risk in common BRCA2 variants.
Oncol Rep
; 19(3): 783-6, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18288416
6.
RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease.
Int J Mol Med
; 22(1): 25-31, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18575772
7.
Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Mutat Res
; 644(1-2): 64-70, 2008 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18694767
8.
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Breast Cancer Res
; 9(5): R59, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17850661
9.
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
Eur J Cancer
; 43(11): 1679-86, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17601725
10.
655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
Cell Oncol
; 29(3): 241-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17452776
11.
Italian Constitution amended to include environmental and health protection: A model for Europe.
Lancet Reg Health Eur
; 16: 100367, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403079
12.
Italy towards permanent daylight saving time? Expected benefits for health, climate and society.
Lancet Reg Health Eur
; 22: 100526, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238951
13.
c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.
Tumori
; 92(4): 311-7, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17036522
14.
HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer.
J Clin Oncol
; 21(14): 2708-12, 2003 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12860948
15.
HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.
Cancer Lett
; 222(1): 75-81, 2005 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15837543
16.
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.
Clin Cancer Res
; 10(16): 5349-54, 2004 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15328171
17.
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study.
Semin Oncol
; 31(2 Suppl 5): 13-9, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15199527
18.
Gonadotropin releasing hormone receptor expression in primary breast cancer: comparison of immunohistochemical, radioligand and Western blot analyses.
Oncol Rep
; 9(5): 1127-32, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12168084
19.
Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: a hospital-based population study.
Tumori
; 90(4): 435-6, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15510991
20.
Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer.
Crit Rev Oncol Hematol
; 89(1): 27-42, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23953684